Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

When the company announced that it was establishing Amarantus Diagnostics as a separate entity and has been moving to clean up its balance sheet and settle the outstanding legal disputes I decided that there is good chance that a joint venture or partnership is in the works which may allow the company to avoid any substantial dilution.

It seemed to me that .081 was a good entry price considering the recent high of .195.

There's a number of catalysts that could easily move this to the .25-.30 range overnight. Risk/reward indicated it was a buy now. If I'm wrong and it goes lower I'll add additional shares.


p.s. I'm also hoping that Oprah will join the company's board of directors in the near future.